Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643

Carcinogenesis

Volumn 18, Issue 11, 1997, Pages 2029-2033

  Peters, Jeffrey M ^a   Cattley, Russell C ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; DNA; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; GENOTYPE; HEPATOMEGALY; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARCINOGENS; DNA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICROBODIES; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0031418657     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.11.2029     Document Type: Article

References (20)

1. Gottlicher, M., Widmark, E., Li, Q. and Gustafsson, J.A. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA, 89, 4653-4657.
2. Issemann, I., Prince, R.A., Tugwood, J.D. and Green, S. (1993) The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol., 11, 37-47.
3. Moody, D.E., Reddy, J.K., Lake, B.G., Popp, J.A. and Reese, D.H. (1991) Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol., 16, 233-248.
4. Motojima, K. (1993) Peroxisome proliferator-activated receptor (PPAR): structure, mechanisms of activation and diverse functions. Cell. Struct. Funct., 18, 267-277.
5. Rao, M.S., Musunuri, S. and Reddy, J.K. (1992) Dehydroepiandrosterone-induced peroxisome proliferation in the rat liver. Pathobiology, 60, 82-86.
6. Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H. and Gonzalez, F.J. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol., 15, 3012-3022.
7. Hayashi, F., Tamura, H., Yamada, J., Kasai, H. and Suga, T. (1994) Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis, 15, 2215-2219.
8. Lalwani, N.D., Reddy, M.K., Qureshi, S.A. and Reddy, J.K. (1981) Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis, 2, 645-650.
9. Reddy, J.K., Rao, S. and Moody, D.E. (1976) Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res., 36, 1211-1217.
10. Reddy, J.K., Rao, M.S., Azarnoff, D.L. and Sell, S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver, Cancer Res., 39, 152-161.
11. Fan, C.Y., Pan, J., Chu, R., Lee, D., Kluckman, K.D., Usuda, N., Singh, I., Yeldandi, A.V., Rao, M.S., Maeda, N. and Reddy, J.K. (1996) Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem., 271, 24698-24710.
12. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis, 16, 1693-1698.
13. Marsman, D.S., Cattley, R.C., Conway, J.G. and Popp, J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in rats. Cancer Res., 48, 6739-6744.
14. Marsman, D.S., Goldsworthy, T.L. and Popp, J.A. (1992) Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis, 13, 1011-1017.
15. Cariot, P. Barrat, E., Mejean L., Pointel, J.P., Drouin, P. and Debbry, G. (1983) Fenotibrate and human liver: Lack of proliferation of peroxisomes. Arch. Toxicol., 53, 151-163.
16. De La Iglesia, F.A., Lewis, J.E., Buchanan, R.A., Marcus, E.L. and McMahon, G. (1982) Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis, 43, 19-37.
17. Maronpot, R.R., Haseman, J K., Boorman, G.A., Eustis, S.E., Rao, G.N. and Huff, J.E. (1987) Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position. Arch. Toxicol. Suppl., 10, 10-26.
18. Eacho, P.I., Lanier, T.L. and Brodhecker, C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1261.
19. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis, 11, 2245-2251.
20. Tugwood, J.D., Aldridge, T.C., Lambe, K.G., MacDonald, N. and Woodyatt, N.J. (1996) Peroxisome proliferator-activated receptors: Structure and function. Ann. N.Y. Acad. Sci., 804, 252-265.